COST OF ILLNESS ANALYSIS OF EPILEPSY OUTPATIENTS USING VALPROIC ACID, PHENYTOIN AND CARBAMAZEPINE THERAPY IN HOSPITAL IN INDONESIA
DOI:
https://doi.org/10.23917/ujp.v3i3.380Keywords:
epilepsy,, cost of illness, outpatient settingsAbstract
Epilepsy is a condition of the onset of attacks in the form of abnormal, irregular brain nerve cell movements, occurring repeatedly and causing temporary motor, sensory or mental function disorders. The treatment of epilepsy has costs that must be known, including direct medical costs, indirect medical costs, and indirect costs; this study aims to determine the cost of illness of epilepsy in one hospital in banyuasin regency with retrospective costing in outpatients. The research method used in this study is a cross-sectional study using patient medical record data and cost data taken from BPJS claims data and hospital rate patterns. This study uses the BPJS perspective and societal perspective, the cost data taken from the BPJS perspective is the result of BPJS claims according to the INACBGs. Package tariff and for the socital perspective the data taken is doctor consultation data, administrative costs, laboratory costs, drug costs and transportation costs and lost productivity costs carried out by interview method for 12 months. The results of this study indicate that the cost of epilepsy outpatients from a societal perspective is Rp.3,141,414 and for BPJS perspective is Rp.2,338,567.
Downloads
References
Begley, C., Wagner, R. G., Abraham, A., Beghi, E., Newton, C., Kwon, C. S., Labiner, D., & Winkler, A. S., 2022. The global cost of epilepsy: a systematic review and extrapolation. Epilepsia, 63(4), 892-903.
Cramer, J. A., Wang, Z. J., Chang, E., Powers, A., Copher, R., Cherepanov, D., & Broder, M. S., 2014. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy & behavior, 31, 356-362.
Gao, L., Xia, L., Pan, S.-Q., Xiong, T., and Li, S.-C., 2015. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Epilepsy research, 110, 146-156.
Jolicoeur, L. M., Jones-Grizzle, A. J., and Boyer, J. G., 1992. Guidelines for performing a pharmacoeconomic analysis. American journal of hospital pharmacy, 49(7), 1741-1747.
Lestari, N. D., 2022. Prevalence of Epilepsy in Dr. Zainoel Abidin Hospital Banda Aceh. Jurnal Kedokteran Syiah Kuala, ISSN: 1412-1026.
Megiddo, I., Colson, A., Chisholm, D., Dua, T., Nandi, A., and Laxminarayan, R., 2016. Health and economic benefits of public financing of epilepsy treatment in India: An agent‐based simulation model. Epilepsia, 57(3), 464-474.
Priyoherianto, A., 2021. Cost-Effectiveness Analysis Biaya Pengobatan Epilepsi Jenis Grand Mal Dengan Beberapa Obat Anti Epilepsi Di Rawat Inap Rsud Sidoarjo. Afamedis, 2(2), 55-62.
Sander, J., and Shorvon, S. D., 1996. Epidemiology of the epilepsies. Journal of neurology, neurosurgery, and psychiatry, 61(5), 433.
Suwarba, I. G. N. M., 2016. Insidens dan karakteristik klinis epilepsi pada anak. Sari Pediatri, 13(2), 123-128.
Tanaka, A., Akamatsu, N., Shouzaki, T., Toyota, T., Yamano, M., Nakagawa, M., and Tsuji, S., 2013. Clinical characteristics and treatment responses in new-onset epilepsy in the elderly. Seizure, 22(9), 772-775.
World Health Organization., 2020, Global Actions on Epilepsy and other neurological disorders. Available at: https://www.who.int/health-topics/epilepsy#tab=tab_1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adi Nurmesa, Dimas Setyadi Putra, Abu Rachman, Wahyudi Wahyudi

This work is licensed under a Creative Commons Attribution 4.0 International License.









